retatrutide logo Premium Costa Rica AlphaGen Retatrutide

Combination with muscle-preserving agents: Companies developing myostatin and activin pathway inhibitors alongside GLP-1RAs are addressing a real unmet need that Novo Nordisk and Eli Lilly are also pursuing but have not yet solved

doi: 10.1111/dom.12639 84 ManigaultKRThurstonMM

Lets break down why some men lose their edge after starting TRT, what to check first, and when to talk to your provider

The risk of thyroid cancer doesnt seem to appear until about the 1-3 year mark

Once-weekly semaglutide versus placebo in adults with increased fracture risk: a randomised, double-blinded, two-centre, phase 2 trial

The modest heart rate increase of 5-10 beats per minute appears tolerable in most patients